| 小檗碱治疗高脂血症研究进展 |
| |
| 引用本文： | 李春利,王雅倩. 小檗碱治疗高脂血症研究进展[J]. 中国药物评价, 2014, 31(1): 19-22 |
| |
| 作者姓名： | 李春利 王雅倩 |
| |
| 作者单位： | 东北制药集团研究院,东北制药集团研究院 |
| |
| 摘 要： | 随着近年血脂异常患者逐渐增加,高脂血症备受关注。现代药理学证实,传统中药小檗碱具有温和的降血脂作用,其作用机制独特,毒副作用小,临床不良反应少,且价低易得,具有现有降脂类药物不可比拟的优势。本文就小檗碱的降血脂药理作用、作用机制、药代动力学、毒理学及临床应用方面进行概括性综述,结果表明小檗碱治疗高脂血症药效明确,毒副作用小,在高脂血症及相关疾病的治疗中前景广阔。
|
| 关 键 词： | 小檗碱 高脂血症 作用机制 临床应用 研究进展 |
| 收稿时间： | 2013-12-30 |
| 修稿时间： | 2013-12-30 |
Research Advance on treating hyperlipidemia of Berberine |
| |
| Affiliation: | NORTHEAST PHARMACEUTICAL GROUP CO.,LTD. Research Institute,NORTHEAST PHARMACEUTICAL GROUP CO.,LTD. Research Institute |
| |
| Abstract: | With the number of blood lipid disorders patients increasing, numerous studies focused on the hyperlipidemia disease. Recent pharmacology studies indicates that berberine, a traditional Chinese medicine, has a goodS cholestorel-lowering activity, unique mechanism of action, low toxic, mild clinicalS adverse events, low cost of treatment and more advantages than the other hypolipidemic drugs. This review summarizes the current research data of pharmacodynamics, mechanisms, pharmacokinetics, toxicology and clinical use. These results indicate that berberine is a effective hypolipidemic drug with good safety and suggest the potential use of berberine for the treatment of hyperlipidemia and other metabolic syndromes. |
| |
| Keywords: | Berberine, Hyperlipidemia, Mechanism of action, Clinical application, Research advance |
|
| 点击此处可从《中国药物评价》浏览原始摘要信息 |
|
点击此处可从《中国药物评价》下载全文 |
|
